BRIEF published on 01/15/2026 at 11:50, 2 months 10 days ago Zürcher Kantonalbank's Disclosure on Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/15/2026 at 11:45, 2 months 10 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank discloses ownership of 0.04% of Avadel Pharmaceuticals plc shares as of 14-Jan-2026, as per Form 8.3 filing with the Irish Takeover Panel Form 8.3 Irish Takeover Panel Ownership Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/14/2026 at 14:35, 2 months 11 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Ordinary Shares Disclosure Irish Takeover Panel Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/14/2026 at 14:30, 2 months 11 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclosed 1.55% stake in Avadel Pharmaceuticals plc on 13th January 2026 Disclosure Irish Takeover Panel Stake Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/06/2026 at 12:50, 2 months 19 days ago Zürcher Kantonalbank Discloses Stake in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/06/2026 at 12:45, 2 months 19 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclose a 0.04% interest in Avadel Pharmaceuticals plc. Details of open stock-settled derivatives positions provided Disclosure Irish Takeover Panel Stock-settled Derivatives Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/05/2026 at 20:35, 2 months 20 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Holding Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/05/2026 at 20:30, 2 months 20 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclosed a 1.02% interest in Avadel Pharmaceuticals plc shares on 2nd January 2026 Shares Disclosure Interests Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/05/2026 at 17:05, 2 months 20 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/05/2026 at 17:00, 2 months 20 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank discloses 1.02% position in Avadel Pharmaceuticals plc as of 31st December 2025 following dealing activities Position Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals Plc 1.02% Dealing Activities
Published on 03/26/2026 at 11:07, 22 minutes ago U.S. Mined and Refined Metals as well as Rare Earth Elements to Be Tokenized in Historic American Strategic Minerals and Datavault AI Deal
Published on 03/26/2026 at 11:00, 29 minutes ago Stagwell Expands the Harris Poll's Harrisquest Across Europe
Published on 03/26/2026 at 08:05, 3 hours 24 minutes ago Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 6 hours 34 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 11:03, 26 minutes ago EQS-Adhoc: VIDINEXT AG: Marketing agreement with Telekom Deutschland GmbH
Published on 03/26/2026 at 11:00, 28 minutes ago Genel Energy PLC: Posting of Annual Report and Notice of AGM
Published on 03/26/2026 at 11:00, 28 minutes ago Genel Energy PLC: Report on payments to governments for the year 2025
Published on 03/26/2026 at 11:00, 29 minutes ago ABB Ltd: ABB share buybacks - March 19, 2026 - March 25, 2026
Published on 03/26/2026 at 11:00, 29 minutes ago Independent study reveals 44% ROI with EQS Compliance Cockpit and payback in under six months
Published on 03/26/2026 at 07:30, 3 hours 59 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 16 hours 57 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 17 hours 44 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
